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/by-nc-We describe a 40-year-old woman with von Hippel-Lindau syndrome, secondary chronic exuda-
tive retinal detachment, and white cataract with consequent leukocoria. Because the cataract was
contracted and calcified, a black Morcher 85F poly(methyl methacrylate) IOL was implanted in the
ciliary sulcus anterior to the lens to prevent posterior capsule rupture and potential destabilization
of the retinal detachment with a risk for phthisis. Excellent centration of the black IOL was achieved
with good cosmetic outcome and without postoperative uveitis or glaucoma. We suggest that this
is a rare indication for implantation of an IOL designed for the sulcus but in the presence of the
crystalline lens. This approach makes IOL removal, if necessary at a later date, relatively
straightforward.
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(http://creativecommons.org/licenses/by-nc-nd/3.0/)The management of cosmetically unacceptable leuko-
coria in blind eyes may be achieved by use of occlusive
contact lenses, corneal tattooing (keratopigmentation),
and implantation of a black intraocular lens (IOL).
Occlusive contact lenses have the advantage of being
easy to fit but require daily maintenance and are
not always tolerated. Keratopigmentation is lessember 23, 2013.
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nd/3.0/).reversible; has poor cosmesis when viewed obliquely
because of parallax; and may be complicated by the
spread of dye beyond the target area, with the risk
for recurrent corneal erosions.1 Occlusive black IOLs
offer a more definitive treatment and have been asso-
ciated with good cosmetic outcomes.2,3 We present a
patient with leukocoria who had successful implanta-
tion of an occlusive IOL in the ciliary sulcus without
sutured fixation.
CASE REPORT
A 40-year-old woman with von Hippel-Lindau syndrome
requested improvement of the cosmetic appearance of her
right pupil, which appeared white. The leukocoria was due
to an intumescent white cataract caused by an underlying to-
tal exudative retinal detachment. The cataract was shrunken
centrally so zonular fibers were visible within the pupil
margin and the ciliary sulcus was deepened. A thick poste-
rior calcified plaque appeared to involve the posterior
capsule. The eye was confirmed to have no light perception.
The fellow eye was structurally normal. The patient had no
systemic symptoms and continued to work as a lawyer.
After informed consent about the off-label use and poten-
tial risks of surgery was obtained, a black occlusive IOL
(model 85F, Morcher GmbH) was implanted. The IOL, which
has a 6.0 mm optic with a 12.0 mm haptic-to-haptic diameter,
was inserted via a scleral tunnel into the ciliary sulcuswithout
removing the crystalline lens. Although eyelets are present onhttp://dx.doi.org/10.1016/j.jcrs.2014.07.007 1565
0886-3350
1566 CASE REPORT: UNSUTURED PHAKIC BLACK IOL FOR LEUKOCORIAeach IOL haptic, sutured fixation was not required; the
IOL was well-centered following removal of the ophthalmic
viscosurgical device. The lens capsulewas not disturbed intra-
operatively. A surgical peripheral iridotomy was performed
in a cosmetically acceptable location under the upper eyelid
to prevent pupillary block (Figure 1).
Twomonths after surgery, the patient remained delighted
with the cosmetic appearance and examination showed
minimal anterior chamber inflammation, a normal intraoc-
ular pressure, and a well-centered IOL. There was no poste-
rior segment view.DISCUSSION
The cosmetic management of leukocoria with the use
of an occlusive poly(methyl methacrylate) (PMMA)
IOL has been reported.2,4,5 Previous cases have
described black IOLs implanted in the capsular bag
following phacoemulsification3,6 or sutured into the
ciliary sulcus in phakic eyes.2,5
We describe a minimally traumatic surgical
approach using an unsutured black IOL in the ciliary
sulcus. Despite there being an intumescent cataract
that could cause lens-induced uveitis because of the
presence of an exudative retinal detachment related
to von Hippel-Lindau syndrome, it was decided not
to perform cataract surgery as posterior capsule
rupture and vitreous loss would risk destabilizing
the chronic retinal detachment and could lead to
phthisis bulbi. Instead, the black IOL was implanted
directly into the ciliary sulcus through a scleral tunnel
with good centration. Sutured fixation risks additional
manipulation within the anterior chamber, riskingJ CATARACT REFRACT SURG - Vdamage to the lens capsule, which might necessitate
lens removal; IOL suturing should therefore be
omitted if not required. Centration of the black IOL
was satisfactory intraoperatively and was maintained
throughout the follow-up period. Although sutured
black IOLs have been described in blind phakic
eyes,2,5 an unsutured surgical approach may reduce
the risk for inadvertent damage of the lens capsule in
the process of sutured fixation.
Reports of phakic black IOL implantation in pa-
tients with leukocoria for retinal detachment, Coats
disease, and cataract are limited. Wong et al.3 report
a case series of 4 eyes that had implantation of the
Morcher 81D black occlusive IOL for leukocoria.
Two patients had primary phacoemulsification and
two, phakic implantation. In all cases, the IOL was
implanted in the ciliary sulcus via a 7.0 mm corneal
section and was associated with good cosmetic out-
comes. Mild IOL subluxation was reported but did
not affect patient satisfaction. Glaucoma occurred in
one patient and was successfully managed with
topical antihypertensive therapy.
Preoperative scotopic pupillometry should be
considered in patients with large pupil diameters in
whom a 6.0 mm occlusive optic may not be sufficient
to prevent a white reflex.6 Options for phakic black
IOL implantation in this patient group include sulcus
fixation of a Morcher 6S PMMA IOL with a 10.0 mm
optic6 or an Ophtec Artisan iris-claw IOL; enclavation
iris fixation may help to overcome difficulty in patients
with large pupil diameters.7 The intended benefits ofFigure 1. Unsutured black IOL implanta-
tion in the ciliary sulcus in an eye with
leukocoria.A: Leukocoria caused by a cen-
trally calcified cataract from an underlying
exudative retinal detachment. Note the
clearer region of the cataract superiorly.
B: Insertion of an occlusive IOL into the
ciliary sulcus via a scleral tunnel incision.
C:Well-positioned IOL in the ciliary sulcus
overlying the cataract. D: The eye after
performance of a cosmetically acceptable
superior peripheral iridotomy to prevent
pupillary block.
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potential risk for glaucoma and endothelial failure
with these implants.
An additional advantage of the 85F occlusive IOL
derives from its spectral transmission characteristics.
The IOL transmits high levels of near-infrared light
above 720 nm, a property not shared by other occlu-
sive IOLs in clinical use.8 This permits imaging of the
posterior segment using scanning laser ophthalmos-
copy or optical coherence tomography.8 Although
the treatment of retinal pathology associated with
leukocoria may not be possible, monitoring intractable
conditions would provide prognostic information
regarding the lifespan of the eye. In eyes with leukoco-
ria and useful visual potential,4 a near infrared–trans-
mitting IOLwould be advisable for structuralmonitoring
of the posterior segment.
In summary, we demonstrate that unsutured phakic
implantation of a black IOL within the ciliary sulcus
achieved stable and effective occlusion in a patient
with leukocoria due to a contracted calcified cataract.
The IOL can be removed easily at a later date if no
longer indicated.J CATARACT REFRACT SURG - VREFERENCES
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